US Patent Issued to Medtronic Ireland Manufacturing UnLtd. on March 25 for "Methods for assessing efficacy of renal neuromodulation and associated systems and devices" (Arizona, California Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,433, issued on March 25, was assigned to Medtronic Ireland Manufacturing UnLtd. Co. (Dublin).

"Methods for assessing efficacy of renal neuromodulation and associated systems and devices" was invented by Carol Sullivan (Litchfield Park, Ariz.) and Stefan Tunev (Santa Rosa, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, devices and compositions for assessing neuromodulation efficacy based on changes in the level of one or more biomarkers in plasma or urine collected from a human subject following a renal neuromodulation procedure."

The patent was filed on Oct. 6, 2021, under Application No. 17/495,595.

*For furth...